• Senate Prepares to Pass Bill Giving FDA Authority to Ban Bio-Identical Hormones
Posted by Joseph F. McWherter, MD on June 4, 2013
The passage of Senate Bill S.959 will adversely affect your access to bio-identical hormone replacement. Legislation has been proposed that would – without alteration – create an environment that would unduly restrict your access to compounded medications, even when your medical providers have determined that this is the best treatment for you.
What does this mean for FEM Centre patients, as well as other patients dependent on compounded prescriptions for their health? Your access to compounded hormone replacement prescriptions for women and men is in danger of being restricted or completely eliminated.
It is not just compounded hormones that would be affected by the passage of this Bill. Options for compounded medications, including those for pain, autism, and for your pets, are at risk of being limited or taken out of your and your medical providers’ hands.
- Your medication options could be diminished.
- You and your medical provider may not be able to do business with the compounding pharmacy that you currently use.
- You may be forced into changing to generic prescriptions – with their accompanying side effects.
The United States Senate will vote on S.959 within the next 2 weeks, so you must act now to stop this Bill from passing. Legislators need to hear that you do not support any policy or law that does not reflect the importance of personalized medicine.
If you live in Texas, contact Senator John Cornyn at (202) 224-2934 and Senator Ted Cruz at (202) 224-5922 to ask them to oppose this bill that would restrict your medical providers from from providing you personalized hormonal replacement therapies with compounded prescriptions.